Journal
NATURE MEDICINE
Volume 16, Issue 9, Pages 991-994Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2202
Keywords
-
Funding
- US Defense Threat Reduction Agency [HDTRA1-07-C-010, 4.10022-08-RD-B, TMTI0048-09-RD-T]
Ask authors/readers for more resources
Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects >60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
